Background
Methods
Ethics statement
Tissue samples
RT-PCR
mRNA in situ hybridization
Antibody generation and identification
Western blot analysis
Immunohistochemistry
Statistical methods
Histological specimens | Grade | Total cases, N | p42.3 expression, n | Percent positive | |
---|---|---|---|---|---|
Positive | Negative | ||||
Astrocytoma | 2 | 11 | 1 | 10 | 9.1% |
OA | 2 | 10 | 1 | 9 | 10% |
Anaplastic OA | 3 | 6 | 0 | 6 | 0 |
GBM | 4 | 11 | 5 | 6 | 45.5% |
Normal tissue | 9 | 0 | 9 | 0 |
Tumor type (histological grade) | p42.3 expression (%) | Sex | Age <50 yr, n | Age ≥50 yr, n | Total ( N) |
---|---|---|---|---|---|
Astrocytoma (grade 2) | Positive (15.9%) | Male | 5 | 1 | 6 |
Female | 4 | 0 | 4 | ||
Negative (84.1%) | Male | 30 | 4 | 34 | |
Female | 18 | 1 | 19 | ||
OD (grade 2) | Positive (9.52%) | Male | 1 | 0 | 1 |
Female | 1 | 0 | 1 | ||
Negative (80.48%) | Male | 10 | 4 | 14 | |
Female | 4 | 1 | 5 | ||
OA (grade 2) | Positive (12.5%) | Male | 1 | 0 | 1 |
Female | 1 | 0 | 1 | ||
Negative (87.5%) | Male | 4 | 5 | 9 | |
Female | 4 | 1 | 5 | ||
Anaplastic OA (grade 3) | Positive (30.0%) | Male | 0 | 1 | 1 |
Female | 2 | 0 | 2 | ||
Negative (70.0%) | Male | 5 | 0 | 5 | |
Female | 2 | 0 | 2 | ||
GBM (grade 4) | Positive (36.5%) | Male | 9 | 5 | 14 |
Female | 4 | 1 | 5 | ||
Negative (63.5%) | Male | 13 | 10 | 23 | |
Female | 6 | 4 | 10 |
Characteristics | OR | 95% CI | P-value |
---|---|---|---|
Sex | 0.4366 | ||
Female | Ref | ||
Male | 1.384 | 0.610 to 3.137 | |
Age | 0.5411 | ||
<50 yr | Ref | ||
≥50 yr | 0.751 | 0.299 to 1.884 | |
Grade | 0.0041* | ||
2 | Ref | ||
3 and 4 | 3.089 | 1.430 to 6.675 |